Circulating apo 2L levels decreased in hepatitis C with the pegilated interferon-2 alpha treatment
Crossref DOI link: https://doi.org/10.1186/1939-4551-8-S1-A8
Published Print: 2015
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yalcin, Ata Nevzat
Yalcin, Arzu Didem
Celik, Betul
Kose, Sukran
Cekin, Ayhan
Seyman, Derya
Gumuslu, Saadet
Text and Data Mining valid from 2015-01-01
Version of Record valid from 2019-07-26
License valid from 2015-01-01